Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01SPJ
|
||||
Former ID |
DIB009765
|
||||
Drug Name |
Litenimod
|
||||
Synonyms |
Li-28; CpG oligonucleotide immunomodulator (cancer), Oligovax
|
||||
Indication | Glioblastoma multiforme [ICD9: 191; ICD10:C71] | Phase 1 | [551464] | ||
Company |
Oligovax SAS
|
||||
Formula |
C256H322N95O129P25S25
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Toll-like receptor 9 | Target Info | Modulator | [543477] | |
NetPath Pathway | BCR Signaling Pathway | ||||
PANTHER Pathway | Toll receptor signaling pathway | ||||
References |
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.